Article Details

Hologic, Thermo Fisher, Qiagen quarterly sales beat estimates on COVID-19 test revenue

Retrieved on: 2022-05-03 15:57:34

Tags for this article:

Click the tags to see associated articles and topics

Hologic, Thermo Fisher, Qiagen quarterly sales beat estimates on COVID-19 test revenue. View article details on hiswai:

Excerpt

Roche expects combined sales of COVID-19 tests and therapeutics to total $5.1 billion in 2022, down from roughly $7.2 billion last year. Roche's COVID ...

Article found on: www.medtechdive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up